217
Views
13
CrossRef citations to date
0
Altmetric
Review

Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives

, , , &
Pages 5423-5436 | Published online: 01 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Wei Cai, Chunyan Geng, Lei Jiang, Jingping Sun, Bin Chen, Ying Zhou, Binfeng Yang & Hailin Lu. (2020) Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity. Pharmaceutical Development and Technology 25:5, pages 640-648.
Read now
Zhe Chen, Yuanqiang Zheng, Yanchun Shi & Zhengrong Cui. (2018) Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles. International Journal of Nanomedicine 13, pages 319-336.
Read now
Xinzhe Yu, Yang Di, Chao Xie, Yunlong Song, Hang He, Hengchao Li, Xinming Pu, Weiyue Lu, Deliang Fu & Chen Jin. (2015) An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. International Journal of Nanomedicine 10, pages 6825-6834.
Read now

Articles from other publishers (10)

Xiongqi Han, Joseph Ho Chi Lai, Jianpan Huang, Se Weon Park, Yang Liu & Kannie Wai Yan Chan. (2021) Imaging Self-Healing Hydrogels and Chemotherapeutics Using CEST MRI at 3 T. ACS Applied Bio Materials 4:7, pages 5605-5616.
Crossref
Pooja Manjarekar & Tabassum Khan. (2021) ANALYTICAL METHOD DEVELOPMENT AND VALIDATION STUDIES OF GEMCITABINE NIOSOMES. INDIAN DRUGS 57:11, pages 45-51.
Crossref
Maria João Bebianno, Thiago Lopes Rocha, Jorge Filipe Pontes, André Corrêa Amaral & Ana Grenha. 2021. Nanopharmaceuticals: Principles and Applications Vol. 2. Nanopharmaceuticals: Principles and Applications Vol. 2 289 317 .
Hassan Tamam, Jinho Park, Hytham H. Gadalla, Andrea R. Masters, Jelan A. Abdel-Aleem, Sayed I. Abdelrahman, Aly A. Abdelrahman, L. Tiffany Lyle & Yoon Yeo. (2019) Development of Liposomal Gemcitabine with High Drug Loading Capacity. Molecular Pharmaceutics 16:7, pages 2858-2871.
Crossref
Junhua Xu, Honglei Tu, Zheng Ao, Yifan Chen, Ryan Danehy & Feng Guo. (2019) Acoustic disruption of tumor endothelium and on-demand drug delivery for cancer chemotherapy. Nanotechnology 30:15, pages 154001.
Crossref
Elena Giuliano, Donatella Paolino, Massimo Fresta & Donato Cosco. (2018) Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations. Medicines 6:1, pages 7.
Crossref
Hima Bindu Ruttala, Thiruganesh Ramasamy, Bijay Kumar Poudal, Yongjoo Choi, Ju Yeon Choi, Jeonghwan Kim, Sae Kwang Ku, Han-Gon Choi, Chul Soon Yong & Jong Oh Kim. (2017) Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy. Oncotarget 8:9, pages 14925-14940.
Crossref
Paul N. Durfee, Yu-Shen Lin, Darren R. Dunphy, Ayşe J. Muñiz, Kimberly S. Butler, Kevin R. Humphrey, Amanda J. Lokke, Jacob O. Agola, Stanley S. Chou, I-Ming Chen, Walker Wharton, Jason L. Townson, Cheryl L. Willman & C. Jeffrey Brinker. (2016) Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells. ACS Nano 10:9, pages 8325-8345.
Crossref
Yuguo Li, Hanwei Chen, Jiadi Xu, Nirbhay N. Yadav, Kannie W. Y. Chan, Liangping Luo, Michael T. McMahon, Bert Vogelstein, Peter C.M. van Zijl, Shibin Zhou & Guanshu Liu. (2016) CEST theranostics: label-free MR imaging of anticancer drugs. Oncotarget 7:6, pages 6369-6378.
Crossref
Yonghou Jiang, Shijie Cao, Danielle K. Bright, Alaina M. Bever, Anna K. Blakney, Ian T. Suydam & Kim A. Woodrow. (2015) Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell–Cell HIV Transmission. Molecular Pharmaceutics 12:12, pages 4363-4374.
Crossref